New Zealand markets closed

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1709-0.0091 (-5.06%)
At close: 04:00PM EDT
0.1788 +0.01 (+4.62%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
97.323
881.705
3,937
36,144
4,822
Operating expenses
Research development
20,245
36,445
98,267
89,605
48,614
Selling general and administrative
19,583
20,425
28,480
23,643
12,956
Total operating expenses
39,828
56,871
126,747
113,248
61,570
Operating income or loss
-39,731
-55,989
-122,810
-77,105
-56,748
Total other income/expenses net
6,340
12,179
12,569
4,423
92.791
Income before tax
-35,123
-45,640
-111,269
-71,454
-55,672
Income from continuing operations
-35,123
-45,640
-111,269
-71,454
-55,672
Net income
-35,123
-45,640
-111,269
-71,454
-55,672
Net income available to common shareholders
-35,123
-45,640
-111,269
-71,454
-55,672
Basic EPS
-
-0.37
-1.42
-1.12
-0.98
Diluted EPS
-
-0.37
-1.42
-1.12
-0.98
Basic average shares
-
122,990
78,133
63,899
57,000
Diluted average shares
-
122,990
78,133
63,899
57,000
EBITDA
-
-54,350
-121,116
-75,875
-56,254